Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Selective inhibition of ELFN2-containing PP1 hinders autophagy and enhances temozolomide sensitivity in glioblastoma

Cancer Letters(2026)10.1016/j.canlet.2026.218667Source: DataRank Database

Selective inhibition of ELFN2-containing PP1 hinders autophagy and enhances temozolomide sensitivity in glioblastoma is a research paper published in Cancer Letters (2026). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: closedTopics (48)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Wei Gao ORCID,Anbo Gao,Kun Deng,Danyang Li ORCID,Jianliang Huang

Live enrichment

PubMed:42276409 OpenAlex:https://openalex.org/W7164400496

National Natural Science Foundation of China

Grant: 82073096

National Natural Science Foundation of China

Grant: 82303362

Key Project of Research and Development Plan of Hunan Province

Grant: 2024DK2006

Health Commission of Hunan Province

Grant: 20231708

Hunan Provincial Natural Science Foundation

Grant: 2025JJ60497

Hunan Provincial Natural Science Foundation

Grant: 2026JJ80660

Hunan Provincial Natural Science Foundation

Grant: 2025JJ30039

FWCI

0.00

Citation Percentile

0.6%

closedLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

publisherhttps://api.elsevier.com/content/article/PII:S0304383526004301?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304383526004301?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.canlet.2026.218667

repositoryhttps://pubmed.ncbi.nlm.nih.gov/42276409

Fields of Study

Autophagy in Disease and TherapyEndoplasmic Reticulum Stress and DiseaseBrain Metastases and TreatmentTemozolomideHumansGlioblastomaAutophagyAnimalsDrug Resistance, NeoplasmCell Line, TumorBrain NeoplasmsProtein Phosphatase 1Antineoplastic Agents, AlkylatingMicePhosphorylationVorinostatRNA-Binding ProteinsXenograft Model Antitumor AssaysRNA, Long NoncodingTranscription FactorsAlternative Splicing

MeSH Terms

TemozolomideVorinostatAnimalsAutophagyBrain NeoplasmsGlioblastomaHumansPhosphorylationTranscription FactorsRNA-Binding ProteinsAlternative SplicingAntineoplastic Agents, AlkylatingDrug Resistance, NeoplasmXenograft Model Antitumor AssaysCell Line, TumorMiceProtein Phosphatase 1RNA, Long Noncoding

Keywords

AutophagyTemozolomideGlioblastomaSensitivity (control systems)Downregulation and upregulationIn vitroAlternative splicingTemozolomide ResistantElfn2-containing Pp1

Sustainable Development Goals

SDG 0: Zero hunger

Selective inhibition of ELFN2-containing PP1 hinders autophagy and enhances temozolomide sensitivity in glioblastoma

FAIR Checklist

Authors (9)

Funding (7 grants)

Impact

Open Access

Topics